Dr. Christine Allen, Co-Founder and CEO of Intrepid Labs, and Dr. Andrew Lewis, Chief Scientific Officer of Quotient Sciences, explain how AI can be used in drug development to shorten development timelines in the latest episode of Pharma Fundamentals.
PharmTech.com serves as a leading information hub for professionals involved in pharmaceutical manufacturing and drug development worldwide. Drawing on the expertise of Pharmaceutical Technology and Pharmaceutical Technology Europe, it delivers comprehensive coverage of topics spanning medicine and healthcare, pharmaceuticals, diagnostics, alternative medicine, natural sciences, as well as emerging fields like artificial intelligence and machine learning within the industry.
The platform’s readership primarily consists of scientists, researchers, regulatory professionals, executives in pharma companies, and other stakeholders who require up-to-date insights into industry trends and technological advancements. PharmTech.com is particularly valuable to those seeking expert commentary on evolving scientific practices or looking for detailed event coverage relevant to pharmaceutical innovation.
PharmTech.com covers its subject matter through a mix of press releases from private sector organizations, expert analysis pieces that interpret new research or regulations, and reports from key industry events. This approach ensures that readers receive both timely news updates and deeper contextual understanding necessary for informed decision-making.
Content is distributed across multiple platforms including print editions for traditional readers as well as robust online digital formats to reach a global audience efficiently.















